BreachRx Honored as a Top Rising in Cyber 2025 Company by Notable Capital
'We built our platform on the belief that incident response should be systematic, orchestrated, and intelligent, not the chaos companies experience today," said Andy Lunsford, CEO and co-founder at BreachRx.
Unlike traditional rankings, Rising in Cyber 2025 honorees were selected through a multi-stage process grounded in real-world practitioner validation. Leading cybersecurity venture firms, including HSBC, Morgan Stanley, and Hitch submitted nominations, and nearly 150 Chief Information Security Officers (CISOs) and senior security executives from organizations such as Adobe, Chime, and Kaiser Permanente voted on the final list. BreachRx is part of a peer group that has collectively raised over $7.8 billion according to Pitchbook as of May 2025, and is defining the next era of cybersecurity across key areas like identity, application security, agentic AI, and security operations. In celebration, winners are being recognized today at the New York Stock Exchange.
'Earning a place on Notable Capital's Rising in Cyber list is a powerful endorsement from some of the most influential decision makers in cybersecurity,' said Andy Lunsford, CEO and co-founder at BreachRx. 'We built our platform on the belief that incident response should be systematic, orchestrated, and intelligent, not the chaos companies experience today. This recognition validates our mission to give organizations not just a playbook, but a true command center for navigating today's relentless threat landscape. We're proud to help organizations take control, move faster, collaborate better, and turn every incident into an opportunity for resilience.'
The BreachRx platform is a secure, central workspace for every stakeholder across an organization to coordinate and streamline cybersecurity incident response management. It enables real-time, cross-functional collaboration by clearly defining roles, responsibilities, and timelines, ensuring every team member knows exactly what to do and when to do it. The platform reduces costs and increases efficiency by automating the creation of tailored playbooks for any type of incident and reports to track and measure response outcomes for Boards, auditors, and regulators.
The Notable Capital led achievement follows a year in which BreachRx achieved more than 3x year-over-year annual recurring revenue (ARR) growth for the second consecutive year. Most recently in May, the company announced the closing of an oversubscribed $15 million Series A funding round, along with the appointment of Ballistic Ventures General Partner and former Mandiant CEO Kevin Mandia to the Board of Directors. BreachRx now serves more than 100 customers, including numerous publicly traded and Fortune 500 companies across financial services, technology, healthcare, and critical infrastructure markets.
'The demand for cybersecurity innovation has never been greater. As the underlying technologies evolve and agentic AI reshapes everything from threat detection to team workflows, we're witnessing a shift from reactive defense to proactive, intelligence-driven operations,' said Oren Yunger, Managing Partner at Notable Capital. 'What makes this list special is that it reflects real-world validation—honorees were chosen by CISOs who face these challenges every day. Congratulations to this year's Rising in Cyber companies for building the solutions that modern security leaders truly want and need.'
For more information on BreachRx or to schedule a demo, please visit breachrx.com.
About BreachRx
BreachRx is the first intelligent incident response platform that provides operational resilience for the entire enterprise. Its patented technology brings order to the chaos before, during, and after incidents by automatically generating tailored incident response plans and providing targeted guidance to relevant stakeholders through every step of the process. Integrated privileged communication channels and audit trails ensure compliance with rapidly evolving standards and proactively protect CISOs and executive leadership from personal liability. BreachRx is based in San Francisco and is backed by Ballistic Ventures and SYN Ventures.
About Rising in Cyber
Rising in Cyber is an annual list recognizing the most innovative startups in cybersecurity as determined by nearly 150 leading CISOs and cybersecurity executives. Nomination criteria included private, venture-backed companies with a primary product focus on cybersecurity and the U.S. as a primary market. For more information about the honorees, participating investors, and methodology, visit www.risingincyber.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Form 8.3 - Life Science REIT plc
BOSTON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the 'Code') 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Life Science REIT plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 3 July 2025 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state 'N/A' N/A Expand 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 1p ordinary – 350,000,000 (ISIN: GB00BP5X4Q29) Interests Short Positions Number % Number % (1) Relevant securities owned and/or controlled: (2) Cash-settled derivatives: 5,080,638 1.45 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 5,080,638 1.45 Expand All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in relation to which subscription right exists: N/A Details, including nature of the rights concerned and relevant percentages: N/A Expand 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/Sale Number of securities Price per unit N/A N/A N/A N/A Expand (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. Opening/Closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit 1p ordinary CFD Increasing a long position 100,000 GBP 0.4400 1p ordinary CFD Increasing a long position 8,111 GBP 0.4390 Expand (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit N/A N/A N/A N/A N/A N/A N/A N/A Expand (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit N/A N/A N/A N/A N/A Expand (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) N/A N/A N/A N/A Expand 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state 'none' None Expand (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state 'none' None Expand (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? No Expand Date of disclosure: 4 July 2025 Contact name: Mary Merrigan Telephone number: +1 617 778 7775 Expand Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at
Business Wire
2 hours ago
- Business Wire
QISITECH Redefines Exhibition Norms at the World Vape Show: A Live Showcase of Automated ODM Mastery
DUBAI, United Arab Emirates--(BUSINESS WIRE)--At the World Vape Show in Dubai (June 18–20, 2025), QISITECH's Geek Design team made a powerful statement by unveiling the industry's first live demonstration of a fully automated vape production line. This groundbreaking showcase highlighted the company's all-in-one ODM model—combining product development, branding, manufacturing, and marketing—with a strong focus on automation, precision, and speed-to-market. Powered by QISI Intelligent Manufacturing, the production line reflected the brand's design-for-manufacturing (DFM) and design-for-automation (DFA) principles. The system featured modular robotics, AI-driven vision systems, real-time quality control, and three automated stages: e-liquid cup assembly, finished product assembly, and packaging. The four machines on display were part of a complete automation ecosystem designed for scalable, high-efficiency output. QISITECH's ODM framework hinges on four core pillars: Product: Rigorous DFM (Design for Manufacturing) and DFA (Design for Automation) assessments ensure designs are production-ready from conception. Branding: Crafting distinct identities for products supported by global compliance (700+ certifications including TPD). Production: Leveraging QISI's 220,000 m² smart manufacturing campus, outfitted with 16 core-tech patents for modular production lines. Marketing: End-to-end support from POS materials to consumer engagement campaigns. The booth also featured popular products like the award-winning RAZ Series, Powered by Raz RYL, KRAZE, and bracelet-style KRAZE LUNA, as well as the high-performance i:FORCE line—showcasing QISITECH's broad development capabilities. What set this showcase apart was its transparency and interactivity. Visitors witnessed every production stage live, gaining insight into how real-time automation and integrated design can transform concepts into retail-ready products efficiently and reliably. QISITECH's strength lies in its 'three-in-one' model—smart manufacturing, digital control, and automation—supported by an agile supply chain that handles both pilot runs and large-scale production. Its rigorous quality systems (PQ, NPI, PE, SQ) and in-house process control ensure high yields with minimal deviation. With an independent R&D institute and design-driven culture, QISITECH continues to accelerate innovation. Future plans include expanded AI automation, age-verification tech, and a stronger end-to-end ODM offering. QISITECH's Dubai showcase re-imagined the trade show paradigm by bringing manufacturing to the forefront. By demonstrating how design, technology, and branding converge in real-time, the brand solidified its role as a leader in automated ODM, proving that innovation thrives where transparency and engineering excellence coexist.
Business Wire
2 hours ago
- Business Wire
Groupe SEB: Monthly Disclosure of the Total Number of Shares and Voting Rights – 30.06.2025
ECULLY, France--(BUSINESS WIRE)--Regulatory News: Groupe SEB (Paris:SK): Issuer Corporate name SEB S.A. Registered office 112 Chemin du Moulin Carron, 69130 Ecully- France Stockmarket Euronext Paris - A ISIN FR0000121709 Numbers of shares and voting rights : A statutory clause imposes an obligation to declare any crossing thresholds in addition to those provided by law, to any person who comes to hold, directly or indirectly, as defined by Articles L. 233-7 and L. 233-9 of the French Commercial Code, 0.5% of the share capital or voting rights, or any multiple of that percentage. Find us on World reference in small domestic equipment and professional coffee machines, Groupe SEB operates with a unique portfolio of 40 top brands (including Tefal, Seb, Rowenta, Moulinex, Krups, Lagostina, All-Clad, WMF, Emsa, Supor), marketed through multi-format retailing. Selling more than 400 million products a year, it deploys a long-term strategy focused on innovation, international development, competitiveness, and client service. Present in over 150 countries, Groupe SEB generated sales €8 billion in 2023 and has more than 31,000 employees worldwide. SEB SA ■ SEB SA - N° RCS 300 349 636 RCS LYON – with a share capital of €55,337,770 – Intracommunity VAT: FR 12300349636
